Lactate dehydrogenase in dermatology practice

Clin Exp Dermatol. 2020 Jul;45(5):539-543. doi: 10.1111/ced.14134. Epub 2019 Nov 21.

Abstract

Lactate dehydrogenase (LDH) is used in dermatology practice, particularly as a prognostic marker for cutaneous lymphoma. LDH is an intracellular enzyme involved in anaerobic glycolysis, and is found at low concentrations in the blood. LDH is produced in every tissue, thus cell damage releases LDH into the circulation, so the causes of elevated LDH levels are multiple. The utility of LDH in dermatology practice is reviewed, alongside current diagnostic and staging guidelines.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Dermatology
  • Disease Progression
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • L-Lactate Dehydrogenase / blood*
  • L-Lactate Dehydrogenase / metabolism
  • Lymphoma / blood
  • Lymphoma / diagnosis*
  • Male
  • Melanoma / pathology*
  • Melanoma / secondary
  • Neoplasm Staging / methods
  • Reference Values
  • Skin Neoplasms / blood
  • Skin Neoplasms / diagnosis*
  • Skin Neoplasms / pathology

Substances

  • L-Lactate Dehydrogenase